Partial Peptide of α-Synuclein Modified with Small-Molecule Inhibitors Specifically Inhibits Amyloid Fibrillation of α-Synuclein
Open Access
- 28 January 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (2) , 2590-2600
Abstract
We have previously reported that pyrroloquinoline quinone (PQQ) prevents the amyloid formation of α-synuclein, amyloid β1–42 (Aβ1–42), and mouse prion protein. Moreover, PQQ-modified α-synuclein and a proteolytic fragment of the PQQ-modified α-synuclein are able to inhibit the amyloid formation of α-synuclein. Here, we identified the peptide sequences that play an important role as PQQ-modified specific peptide inhibitors of α-synuclein. We demonstrate that the PQQ-modified α-Syn36–46 peptide, which is a partial sequence of α-synuclein, prevented α-synuclein amyloid fibril formation but did not inhibit Aβ1–42 fibril formation. In addition, the α-synuclein partial peptide modified with other small-molecule inhibitors, Baicalein and epigallocatechin gallate (EGCG), prevented α-synuclein fibril formation. Currently reported quinone amyloid inhibitors do not have selectivity toward protein molecules. Therefore, our achievements provide a novel strategy for the development of targeted specific amyloid formation inhibitors: the combination of quinone compounds with specific peptide sequence from target proteins involved in amyloid formation.Keywords
This publication has 31 references indexed in Scilit:
- Inhibition of Amyloid FormationJournal of Molecular Biology, 2012
- Modulating Self‐Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and MechanismsChemMedChem, 2012
- A Century of Alzheimer's DiseaseScience, 2006
- A century-old debate on protein aggregation and neurodegeneration enters the clinicNature, 2006
- Peptide‐Based Inhibitors of Amyloid Assembly2006
- Alpha-synuclein dysfunction in Lewy body diseasesMovement Disorders, 2005
- Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates FibrilsChemistry & Biology, 2004
- Dopamine and L‐dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's diseaseThe FASEB Journal, 2004
- Caught in the ActNeuron, 2003
- Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein AdductScience, 2001